These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9890589)

  • 1. Effects of clozapine for non-treatment-resistant patients with schizophrenia.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Psychiatr Serv; 1999 Jan; 50(1):101-3. PubMed ID: 9890589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
    Still DJ; Dorson PG; Crismon ML; Pousson C
    Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study.
    Silver H; Kushnir M; Kaplan A
    Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning.
    Grace J; Bellus SB; Raulin ML; Herz MI; Priest BL; Brenner V; Donnelly K; Smith P; Gunn S
    Psychiatr Serv; 1996 Jan; 47(1):41-5. PubMed ID: 8925344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.
    Kishi T; Fujita K; Furukawa O; Suzuki T; Moriwaki M; Nitta M; Hattori M; Tsunoka T; Chekuri R; Kane JM; Correll CU; Iwata N
    Asian J Psychiatr; 2013 Jun; 6(3):200-7. PubMed ID: 23642976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restarting clozapine: a case report.
    Barrons E; Johnson E; Nynkowski P
    Psychiatr Serv; 1996 Jan; 47(1):92. PubMed ID: 8925356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of clozapine: effect on negative symptoms].
    Llorca PM; Lançon C; Auquier P; Bougerol T
    Encephale; 1996; 22(4):287-92. PubMed ID: 9035984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to clozapine response in a standardized trial.
    Conley RR; Carpenter WT; Tamminga CA
    Am J Psychiatry; 1997 Sep; 154(9):1243-7. PubMed ID: 9286183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
    Ziegenbein M; Sieberer M; Calliess IT; Kropp S
    Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
    Gunduz-Bruce H; Oliver S; Gueorguieva R; Forselius-Bielen K; D'Souza DC; Zimolo Z; Tek C; Kaliora S; Ray S; Petrides G
    Schizophr Res; 2013 Feb; 143(2-3):344-7. PubMed ID: 23219861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.